TAXIS PHARMACEUTICALS
TAXIS Pharmaceuticals is a privately held biopharmaceutical company dedicated to developing compounds to target the growing threat of antimicrobial resistance, including antibacterial and antiviral resistance. We are currently focused on antibiotic agents that employ novel mechanisms of action distinct from those currently in clinical use. Our team’s expertise in discovery chemistry, combined with our spirit of innovation, allows us to quickly pinpoint promising compounds that exhibit the key properties required for a clinical drug candidate.
TAXIS PHARMACEUTICALS
Social Links:
Industry:
Biopharma Biotechnology Pharmaceutical
Founded:
2009-01-01
Address:
Monmouth Junction, New Jersey, United States
Country:
United States
Website Url:
http://www.taxispharma.com
Total Employee:
1+
Status:
Active
Contact:
(732)230-3074
Total Funding:
8.9 M USD
Technology used in webpage:
Google Google Cloud
Similar Organizations
Idera Pharmaceuticals
Idera Pharmaceuticals is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
Jeil Pharmaceutical
Jeil Pharmaceutical is a contributed to the growth and development of the pharmaceutical industry.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
Current Employees Featured
Founder
Investors List
National Institute of Allergy and Infectious Diseases
National Institute of Allergy and Infectious Diseases investment in Grant - TAXIS Pharmaceuticals
CARB-X
CARB-X investment in Grant - TAXIS Pharmaceuticals
Official Site Inspections
http://www.taxispharma.com Semrush global rank: 9.68 M Semrush visits lastest month: 331
- Host name: server3.bowerwebsolutions.com
- IP address: 67.227.237.65
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917
More informations about "TAXIS Pharmaceuticals"
About – TAXIS Pharmaceuticals
At TAXIS Pharmaceuticals, our mission is clear: to combat antimicrobial resistance and save lives. Antimicrobial resistance demands immediate, … See details»
TAXIS Pharmaceuticals - Crunchbase Company …
TAXIS Pharmaceuticals is a privately held biopharmaceutical company … See details»
Addressing the root cause of antimicrobial resistance.
Dr. Kimball served as Vice President of Chemistry at Lexicon Pharmaceuticals, where he was responsible for building an organization … See details»
TAXIS Pharmaceuticals - Craft
TAXIS Pharmaceuticals has 5 employees at their 1 location. See insights on TAXIS Pharmaceuticals including office locations, competitors, revenue, financials, executives, … See details»
TAXIS Pharmaceuticals, Inc. | LinkedIn
TAXIS Pharmaceuticals is a biotech company devoted to combatting the serious and deadly societal threat of antibiotic resistance by creating … See details»
TAXIS Pharmaceuticals - Products, Competitors, Financials, …
The World Health Organization (WHO) recently named AMR one of the top global public health and development threats. ... Website: www.taxispharma.com. References 2. Antimicrobial … See details»
TAXIS Pharmaceuticals - Overview, News & Similar companies
Jan 14, 2020 Who is TAXIS Pharmaceuticals. TAXIS Pharmaceuticals, Inc. is a clinical stage company developing anti-resistance drug candidates that enable the re-use of the most widely … See details»
TAXIS Pharmaceuticals Company Profile | Management and
Www.taxispharma.com TAXIS Pharmaceuticals Profile and History TAXIS Pharmaceuticals, Inc. is a clinical stage company developing anti-resistance drug candidates that enable the re-use of … See details»
TAXIS Pharmaceuticals, Inc. Company Overview, Contact Details ...
Taxispharma received financing of $2.67M in grant on May 1st '24. NORTH BRUNSWICK, N.J., May 1, 2024 /PRNewswire-PRWeb/ - TAXIS Pharmaceuticals, a clinical stage company … See details»
TAXIS Pharmaceuticals, Inc. Information - RocketReach
Founded in March, 2009, TAXIS Pharmaceuticals is focused on the discovery and development of pharmaceuticals targeting multidrug-resistant bacterial pathogens that constitute a worldwide … See details»
TAXIS Pharma - 2025 Company Profile - Tracxn
May 29, 2025 TAXIS Pharma has raised a total funding of $7.58M over 10 rounds. Its first funding round was on 2009. Its latest funding round was a Grant (prize money) round on May … See details»
TAXIS Pharmaceuticals Announces CARB-X Award of $3.2 Million, …
Jan 14, 2020 Gregory G. Mario, CEO [email protected] www.taxispharma.com TAXIS Pharmaceuticals, Inc. 9 Deerpark Drive Monmouth Junction, NJ 08852 (732) 230-3074 … See details»
CARB-X funds TAXIS Pharmaceuticals to accelerate development …
Jan 8, 2020 [email protected] +1 732 230 3074 About CARB-X Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) is a global non-profit partnership … See details»
TAXIS Pharmaceuticals Announces $2.67 Million NIH Grant
Dr. Kimball served as Vice President of Chemistry at Lexicon Pharmaceuticals, where he was responsible for building an organization of over 75 chemists, including medicinal, analytical, … See details»
Authority Magazine Interview – TAXIS Pharmaceuticals
Dr. Kimball served as Vice President of Chemistry at Lexicon Pharmaceuticals, where he was responsible for building an organization of over 75 chemists, including medicinal, analytical, … See details»
TAXIS Pharmaceuticals - VentureRadar
TAXIS Pharmaceuticals is developing pharmaceuticals targeting multidrug-resistant bacterial pathogens. The company\`s lead candidates, referred to as... ... Find out ... See details»
TAXIS Pharmaceuticals appears in August special issue on …
Dr. Kimball served as Vice President of Chemistry at Lexicon Pharmaceuticals, where he was responsible for building an organization of over 75 chemists, including medicinal, analytical, … See details»
TAXIS Pharmaceuticals Receives $2.9 Million NIH Grant for its …
May 27, 2025 The MarketWatch News Department was not involved in the creation of this content. TAXIS has received a $2.9 million grant to further advance R&D efforts for its … See details»
Pipeline – TAXIS Pharmaceuticals
TAXIS Pharmaceuticals is researching new classes of anti-resistance agents that employ novel mechanisms of action. We are focusing our science on the disruption of the foundation of … See details»
Innovative Approaches to Antibiotic Resistance: The Promise of …
The increasing prevalence of multi-drug-resistant (MDR) infections is a significant and urgent challenge for public health globally. As pathogens become resistant to commonly used … See details»